Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
MDA
4-AcO-MET
GABAergic hallucinogens
Paradise island by Xanny.jpgParadise island by Subsentience
4-HO-MPT
Memantine
3C-E
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
ETH-LAD
4-FA
Pramiracetam
ΑMT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
25D-NBOMe
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
1B-LSD
LSM-775
Experience:BK-2C-B - Various experiences
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
4-AcO-DET
DiPT
4-HO-DET
4-HO-MiPT
2C-T-21
DOB
Bromo-DragonFLY
25B-NBOH
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
2C-T-2
Methallylescaline
DOM
ALD-52
25I-NBOMe
Amanita muscaria
Experience:40mg - Brothermind and the Forest's Hand
DOC
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:3g mimosa / 3g syrian rue - Connecting with my body
3-MMC
Experience:3-MeO-PCP - Extreme psychosis
Coluracetam
Efavirenz
6-APDB
Experience:4-AcO-DMT + 200mg Pill
Pregabalin
Psilocybin mushrooms
25B-NBOMe
DOI
DMT
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
AL-LAD
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:800 seeds LSA - My First Trip Ever
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Proscaline
Experience:~150mg MDA(oral) - a case of mistaken identity
JWH-018
2C-P
2C-B
2C-E
4-AcO-MiPT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
25C-NBOMe
THJ-2201
Experience:300µg AL-LAD - Don't worry, because you're everyone!
MET
2C-H
Psilocin
Phenylpiracetam
3-MeO-PCE
Experience:25mg Deschloroketamine - My first time orally dosing DCK
4-AcO-DiPT
2C-D
DPT
Experience:337mg DMT fumarate - A Day With DMT
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
5-MeO-DiPT
5-MeO-MiPT
25N-NBOMe
TMA-2
Experience:250mg DXM - DXM Itch and Trip Report
Experience:4.5g - The Grand Introduction to Beauty and Fear
THJ-018
Experience:2 tabs DOB - My DOB Nightmare
6-APB
25C-NBOH
PARGY-LAD
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Enhancement of colour rose.jpgRose by Chelsea Morgan
Selective serotonin reuptake inhibitor
25I-NBOH
MDAI
Cannabis
Experience:1000 Morning Glory seeds - Rediscovering the Self
Escaline
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
MDMA
Tree.jpgJapanese Garden by Anonymous
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
MDEA
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
JWH-073
LSZ
2C-B-FLY
LSA
1P-ETH-LAD
MiPT
2C-C
4-HO-DiPT
Aniracetam
Bufotenin
Omberacetam
Experience:120mg - Garden of The Gods
Oxiracetam
2C-T-7
2C-I
1P-LSD
DET
PRO-LAD
Allylescaline
5-Hydroxytryptophan
LSD
Piracetam
4-AcO-DMT
EPT
Βk-2C-B
Ibogaine
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
MiPLA
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
TMA-6
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
4-HO-MET
4-HO-EPT
Experience:4x 200ug tabs - You do not need to understand
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Mescaline
Experience:1050 µg 1cP-LSD - The matrix
Chameleon.jpgChameleon by Anonymous.
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
4-HO-DPT
Experience:1mg 25c-NBOMe - Experiment in my room
5-MeO-DALT
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:25mg 3-MeO-PCP - Enhanced film experience
MPT
Ayahuasca

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.